Literature DB >> 9846496

Telomerase activity in hepatocellular carcinoma and adjacent liver tissues.

K Kishimoto1, J Fujimoto, M Takeuchi, H Yamamoto, T Ueki, E Okamoto.   

Abstract

BACKGROUND AND OBJECTIVES: Activation of telomerase and stabilization of telomeres are considered necessary for immortalization of tumor cells. Telomerase activity was analyzed in 69 hepatocellular carcinomas and adjacent chronic liver disease tissues. The telomerase activity level was examined in relation to clinicopathologic features.
METHODS: Telomerase activity was determined by a telomeric repeat amplification protocol. Immature and mature leukocytes were removed from homogenized tissue of adjacent livers using anti-CD45 and anti-CD15 monoclonal antibody-coated magnetic beads.
RESULTS: Telomerase activity was detected in hepatocellular carcinomas and leukocytes, but not in liver cells from adjacent chronic liver disease tissues after the separation of leukocytes. All hepatocellular carcinomas displayed telomerase activity, and the activity level correlated with the degree of differentiation (P=0.021) and patient survival (P=0.039).
CONCLUSIONS: These results indicate that activation of telomerase may be required as a critical step in hepatocarcinogenesis and tumor development, and detection of telomerase activity with removal of contaminating leukocytes may be useful in the characterization or prognostication of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846496     DOI: 10.1002/(sici)1096-9098(199811)69:3<119::aid-jso1>3.0.co;2-q

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Fumagillin treatment of hepatocellular carcinoma in rats: an in vivo study of antiangiogenesis.

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Wen-Juei Jeng; Chi-Juei Jeng; Yi-Ching Wang; Shu-Ling Gu; Shin-Yun Tseng; Chien-Ming Chu; Chia-Hui Lin; Kuo-Ming Chang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

2.  Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.

Authors:  Yan-Shen Shan; Yu-Hsiang Hsieh; Pin-Wen Lin
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

3.  Human telomerase activity, telomerase and telomeric template expression in hepatic stem cells and in livers from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lola M Reid
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-10       Impact factor: 2.566

4.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

5.  Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma.

Authors:  Mirko Tarocchi; Simone Polvani; Anna Julie Peired; Giada Marroncini; Massimo Calamante; Elisabetta Ceni; Daniela Rhodes; Tommaso Mello; Giuseppe Pieraccini; Alessandro Quattrone; Claudio Luchinat; Andrea Galli
Journal:  J Hepatol       Date:  2014-05-23       Impact factor: 25.083

6.  Effects of treatment with platinum azidothymidine and azidothymidine on telomerase activity and bcl-2 concentration in hepatocellular carcinoma- induced rats.

Authors:  Abdolreza Sabokrouh; Mohammad Taghi Goodarzi; Asad Vaisi-Raygani; Shohreh Khatami; Masoud Taghizadeh-Jahed
Journal:  Avicenna J Med Biotechnol       Date:  2014-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.